Singapore markets closed

  • Straits Times Index

    3,204.82
    +2.01 (+0.06%)
     

  • Nikkei

    32,402.41
    -168.62 (-0.52%)
     

  • Hang Seng

    18,057.45
    +402.04 (+2.28%)
     

  • FTSE 100

    7,683.91
    +5.29 (+0.07%)
     

  • Bitcoin USD

    26,556.50
    -15.96 (-0.06%)
     

  • CMC Crypto 200

    565.87
    -2.18 (-0.38%)
     

  • S&P 500

    4,320.06
    -9.94 (-0.23%)
     

  • Dow

    33,963.84
    -106.58 (-0.31%)
     

  • Nasdaq

    13,211.81
    -12.18 (-0.09%)
     

  • Gold

    1,944.90
    +5.30 (+0.27%)
     

  • Crude Oil

    90.33
    +0.70 (+0.78%)
     

  • 10-Yr Bond

    4.4380
    -0.0420 (-0.94%)
     

  • FTSE Bursa Malaysia

    1,450.23
    +2.02 (+0.14%)
     

  • Jakarta Composite Index

    7,016.84
    +25.38 (+0.36%)
     

  • PSE Index

    6,142.79
    +48.08 (+0.79%)
     

Incyte to Present at Upcoming Investor Conferences

Business Wire
·1-min read

WILMINGTON, Del., April 18, 2023--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of May:

  • Bank of America 2023 Health Care Conference on Wednesday, May 10, 2023 at 10:40 a.m. (PDT)

  • 2023 RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023 at 10:30 a.m. (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230418005078/en/

Contacts

Incyte Contacts
Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Christine Chiou
+1 302 274 4773
cchiou@incyte.com